Zimmer Biomet Holdings, Inc. (ZBH) Q3 2022 Earnings Results

Zimmer Biomet Holdings Beats on EPS, Stock Down 3.71%

Zimmer Biomet's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock fell by 3.71% following the announcement, likely due to the lack of revenue details and no updated guidance. Investors may be concerned about ongoing supply chain issues and their impact on future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.58	N/A	+1.41%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a cautious optimism about the company's ability to navigate current challenges. They emphasized a focus on operational improvements and long-term strategies.

Management highlighted ongoing challenges in the supply chain but expressed confidence in long-term growth.

They noted improvements in operational efficiency as a positive sign for future performance.

Zimmer Biomet Holdings Beats on EPS, Stock Down 3.71%

Key numbers

Management commentary

Zimmer Biomet Holdings, Inc.

More earnings this week

Zimmer Biomet Holdings Beats on EPS, Stock Down 3.71%

Key numbers

Management commentary